Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical announced its financial results for the quarter ending December 2024, reporting net sales of Rs 33.21 crore, a notable year-on-year increase. However, the company faced challenges with a decline in profit before tax and operating profit, indicating difficulties in maintaining profitability.

Oxygenta Pharmaceutical, a microcap company in the pharmaceuticals and drugs industry, has reported positive financial results for the quarter ending September 2024. Despite a 'Sell' call from MarketsMOJO, the company's PAT has increased by 130.17% and net sales have reached a five-quarter high. This shows a promising trend for the company's financial performance.

Oxygenta Pharmaceutical, a microcap pharmaceutical company, has been downgraded to a 'Sell' by MarketsMOJO due to negative book value, weak fundamental strength, and high debt to equity ratio. Despite a significant return in the past year, profits have only increased by 96.8%. Promoters have increased their stake, but overall outlook is not favorable.

Oxygenta Pharmaceutical, a microcap company in the pharmaceuticals and drugs industry, has reached a new milestone with its stock price hitting a 52-week high of Rs. 108.64 on October 28, 2024. The stock has outperformed its sector and consistently traded at its opening price, with a remarkable 80.11% increase in the past 21 days. With a Hold rating from MarketsMOJO and a strong 1-year performance of 323.71%, the company shows potential for growth in the market.

Oxygenta Pharmaceutical, a microcap company in the pharmaceuticals and drugs industry, has seen a remarkable 80.11% increase in returns in the past 21 days, reaching an all-time high price of Rs.108.64 on October 28, 2024. The stock has been trading above its moving averages and has shown a 323.71% increase in the past year, indicating strong growth potential.

Oxygenta Pharmaceutical, a microcap company, has seen a significant increase in its stock price, reaching an all-time high of Rs.106.51 on October 27, 2024. The stock has outperformed the sector by 2.22% and has been on a consecutive upward trend for the past 21 days, with a remarkable 85.4% increase in returns. Its strong performance and innovative products have caught the attention of investors and analysts.

Oxygenta Pharmaceutical's stock has reached an all-time high of Rs.106.51, outperforming the pharmaceutical sector by 2.22%. With a consecutive 21-day upward trend and a remarkable 85.4% increase in returns, the company's strong performance and potential for growth make it an attractive option for investors.

Oxygenta Pharmaceutical, a microcap company, has seen a surge in its stock price, reaching a 52-week high and outperforming the sector by 2.03%. The stock has maintained a stable price and is trading higher than its moving averages, indicating a positive trend. With a 1-year performance of 285.91%, the company shows strong growth and potential in the pharmaceutical industry. MarketsMOJO suggests holding onto stocks for now.

Oxygenta Pharmaceutical, a microcap company in the pharmaceutical industry, has seen a significant increase in its stock price, reaching an all-time high of Rs.106.51 on October 25th, 2024. The stock has been on a steady upward trend, outperforming the sector by 2.09% and trading higher than its moving averages. This shows promising growth for the company and its potential in the market.

Oxygenta Pharmaceutical, a microcap company, has reached a 52-week high on October 24th, 2024. The stock has been performing well, with a consecutive gain for the last 21 days and a rise of 90.84%. According to financial analysis platform MarketsMOJO, the stock has been given a 'Hold' call. It is currently trading at a consistent price of Rs.104.43, higher than its moving averages and outperforming the market.

Oxygenta Pharmaceutical, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching an all-time high of Rs.104.43 on October 24, 2024. The stock has outperformed the sector and is currently trading above its moving averages, showcasing its strong performance and potential for growth.

Oxygenta Pharmaceutical's stock has reached a 52-week high on October 23, 2024, outperforming the sector by 1.7%. According to MarketsMOJO, the current call for the stock is 'Hold' based on its impressive performance in the past year with a 252.46% increase. The company's consistent gains and strong performance in the pharmaceutical industry have contributed to its success.

Oxygenta Pharmaceutical, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching an all-time high on October 23, 2024. The stock has been on an upward trend for the past 21 days, rising by 97.66%. It has outperformed the sector by 1.7% and is currently trading above its moving averages.

Oxygenta Pharmaceutical, a microcap pharmaceutical company, has reached a new milestone with its stock hitting a 52-week high of Rs.100.39 on October 22, 2024. The stock has outperformed its sector by 1.86% and has shown a consecutive gain streak for the past 21 days. With a 'Hold' call from MarketsMOJO and consistently trading above its moving averages, the company shows strong growth potential for investors.

Oxygenta Pharmaceutical, a microcap company, has seen a significant rise in its stock price, reaching an all-time high on October 22, 2024. The stock has gained 96.84% in the past 21 days and is currently trading at Rs.100.39, outperforming the sector by 1.86%. The company's strong performance and potential for growth make it a promising player in the pharmaceutical industry.

Oxygenta Pharmaceutical, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on October 21, 2024. The company's stock has been on an upward trend for 21 days, gaining 100.88% in returns. Rated as 'Hold' by MarketsMOJO, the stock has outperformed the sector and is currently trading above all its moving averages. With a strong performance and potential for growth, Oxygenta Pharmaceutical is a company to watch in the pharmaceutical industry.

Oxygenta Pharmaceutical, a microcap company in the pharmaceuticals and drugs industry, has reached an all-time high price of Rs.98.43 on October 21, 2024. The stock has been consistently gaining for the past 21 days, with a consecutive rise of 100.88%. It has also outperformed the sector by 2.32% today and has shown a remarkable 1-year performance of 222.83%. MarketsMOJO has given a 'Hold' call for the stock, indicating its strong position in the market.

Oxygenta Pharmaceutical, a microcap company in the pharmaceuticals and drugs industry, has reached an all-time high stock price of Rs.96.5 on October 20, 2024. The stock has been on a consecutive upward trend for the past 20 days, with a remarkable 96.94% increase in returns. It is currently outperforming its sector and has shown impressive growth compared to the Sensex.

Oxygenta Pharmaceutical, a microcap company in the pharmaceuticals and drugs industry, has reached an all-time high stock price of Rs.96.5 on October 19, 2024. With a consecutive gain of 96.94% in the past 20 days and outperforming the sector by 1.67%, the company's strong performance and potential for growth are evident.